Symptoms and Complications of Adult Diabetic Patients in a Family Practice

Archives of Family Medicine

Volumn 5, Issue 3, 1996, Pages 135-145

  Konen, Joseph C ^a,b   Curtis, Laura G ^a   Summerson, John H ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALBUMINURIA; ARTICLE; CROSS-SECTIONAL STUDY; DIABETIC NEUROPATHY; FATIGUE; GENERAL PRACTICE; HUMAN; IMPOTENCE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; RISK FACTOR; VASCULAR DISEASE;

ADULT; AGED; ALBUMINURIA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FAMILY PRACTICE; FATIGUE; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; VASCULAR DISEASES;

EID: 0030094779     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.5.3.135     Document Type: Article

References (54)

1. Centers for Disease Control and Prevention. Surveillance for diabetes mellitus - United States, 1980-1989. MMWR CDC Surveill Summ. 1993;42(SS-2):1-20.
2. National Center for Health Statistics, Schoenborn CA. Health promotion and disease prevention: United States. Vital Health Stat 10. 1988;No. 163.
3. Center for Economic Studies in Medicine. Direct and Indirect Costs of Diabetes in the United States in 1987. McLean, Va: American Diabetes Association; 1988.
4. WHO Expert Committee on Diabetes Mellitus. Second report. WHO Tech Rep Ser. 1989;646:9-14.
5. Konen JC, Shihabi ZK, Newman J. The association of NIDDM and hypertension with urinary excretion of albumin and transferrin. Am J Kidney Dis. 1993; 22:791-797.
6. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Md: National Heart, Lung, and Blood Institute; 1993. National Institutes of Health publication 93-1088.
7. McCormick CP, Shihabi ZK, Konen JC. Microtransferrinuria and microalbuminuria: enhanced immunoassay. Ann Clin Lab Sci. 1989;19:444-451.
8. Rothman KJ, Boice JD. Epidemiologic Analysis With a Programmable Calculator. Boston, Mass: Epidemiology Resources Inc; 1982:19-24.
9. Kelinbaum DG, Kupper HL, Morgenstern H. Epidemiologic Research, Principals and Quantitative Methods. Belmont, Calif: Lifetime Learning Publications; 1982.
10. Daniel WW. Applied Nonparametric Statistics. Boston, Mass: Houghton Mifflin Co; 1978:300-304.
11. Diabetes in North Carolina. Raleigh, NC: Diabetes Control Program, Division of Adult Health, Dept of Environment, Health and Natural Resources, State of North Carolina; 1993. Publication 14G-2/39.
12. Harris MI, Hamman RF, eds. Diabetes in America. Washington, DC: Dept of Health and Human Services, 1985. National Institutes of Health publication 85-1468.
13. Wagenknecht LE, Roseman JM, Alexander WJ. Epidemiology of IDDM in black and white children in Jefferson County, Alabama, 1979-1985. Diabetes. 1989; 38:629-633.
14. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993; 328:1676-1685.
15. Naliboff BD, Rosenthal M. Effects of age on complications in adult onset diabetes. J Am Geriatr Soc. 1989;37:838-842.
16. Laffel LMB, Krolewski AS, Rand LI, Warran JH, Christlieb AR, D'Elia JA. The impact of blood pressure on renal function in insulin-dependent diabetes. Kidney Int. 1987;31:207.
17. Evanoff GV, Thompson CS, Brown J, Weinman EJ. The effect of dietary protein restriction on the progression of incipient diabetic nephropathy in a 12-month follow-up. Arch Intern Med. 1987;147:492-495.
18. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet. 1986;2:1300-1304.
19. McCrary RE, Pitts TO, Puschett JB. Diabetic nephropathy: natural course, survivorship and therapy. Am J Nephrol. 1981;1:206-218.
20. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983;25:496-501.
21. Ballard DJ, Humphrey LL, Melton LJ III, et al. Epidemiology of persistent proteinuria in type II diabetes mellitus: population-based study in Rochester, Minnesota. Diabetes. 1988;37:405-412.
22. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care. 1978; 1:168.
23. Litem L, Feldman M, Procci W, et al. Symptoms of sexual dysfunction and depression in diabetic women. J Diabetes Complications. 1991;5:38-41.
24. The DCCT Research Group. Factors in development of diabetic neuropathy: baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes. 1988;37:476-481.
25. American Diabetes Association Position Statement. Foot care in patients with diabetes mellitus. Diabetes Care. 1992;15:(suppl 2):19-20.
26. National Society to Prevent Blindness. Vision Problems in the US: Data Analysis: Definitions, Data Sources, Detailed Data Table, Analysis, Interpretation. New York, NY: National Society to Prevent Blindness; 1980:1-18.
27. Pugh JA, Wiley R, Tuley MR, et al. Diabetic retinopathy screening: the non-mydriatic camera (NMRC) performs mydriatically. Diabetes. 1990;39(suppl 1): 170. Abstract.
28. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA. 1979;241:2035-2038.
29. Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication, and risk of cardiovascular events: the Framingham Study. Diabetes. 1989;38: 504-509.
30. Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano K. Diabetes and the risk of stroke. JAMA. 1987;257:949-952.
31. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I. Atherosclerotic vascular disease and its risk factors in NIDDM subjects in Finland. Diabetes Care. 1988;11:449.
32. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women: the Framingham Study. Ann Intern Med. 1977;87:393-397.
33. Singer DE, Nathan DM, Anderson KM, Wilson PWF, Evans JC. Association of HgbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes. 1993;41:202-208.
34. Mattock MB, Keen H, Viberti GC, et al. Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin dependent) diabetic patients. Diabetologia. 1988;31:82-87.
35. Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin dependent diabetes: a 10-year follow-up study of 503 patients. Diabet Med. 1988; 5:126-134.
36. Zavaroni I, Bonora E, Pagliara M, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 1989;320:702-706.
37. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990; 263:2893-2898.
38. Rowe DJ, Dawnay A, Watts GF. Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in the urine. Ann Clin Biochem. 1990;27(pt 4):297-312.
39. Rudberg S, Aperia A, Freyschuss U, Persson B. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of hypotensive effect. Diabetologia. 1990;33:470-476.
40. The Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria: a preliminary multicenter trial. N Engl J Med. 1984;311:365-372.
41. Gatling W, Mullee MA, Knight C, Hill RD. Microalbuminuria in diabetes: relationships between urinary albumin excretion and diabetes-related variables. Diabet Med. 1988;5:348-351.
42. Konen JC, Shihabi ZK. Microalbuminuria and diabetes mellitus. Am Fam Physician. 1993;48:1421-1428.
43. Robertson WB, Strong JP. Atherosclerosis in persons with hypertension and diabetes mellitus. Lab Invest. 1968;18:78-91.
44. Crouse JR, Toole JF, McKinney WM, et al. Risk factors for extracranial carotid artery atherosclerosis. Stroke. 1987;18:990-996.
45. Tell GS, Howard G, McKinney WM. Risk factors for sites specific extracranial carotid artery distribution as measured by B-mode ultrasound. J Clin Epidemiol. 1989;42:551-559.
46. Lloyd CE, Matthews KA, Win RA, Orchard TJ. Psychological factors and complications of IDDM, VIII: The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 1992;15:166-172.
47. Perlmuter LC, Hakami MK, Hodgson-Harrington C, et al. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med. 1984; 77:1043-1048.
48. Harris MI. Testing for blood glucose by office-based physicians in the U.S. Diabetes Care. 1990;13:419-426.
49. Weiner JP, Parente ST, Garnick DW, Fowles J, Lawthers AG, Palmer RH. Variation in office-based quality: a claims-based profile of care provided to Medicare patients with diabetes. JAMA. 1995;273:1503-1508.
50. Kenny SJ, Smith PJ, Goldschmid MG, Newman JM, Merman WH. Survey of physician practice behaviors related to diabetes mellitus in the U.S. Diabetes Care. 1993;16:1507-1510.
51. American Diabetes Association. Standards for medical care for patients with diabetes mellitus. Diabetes Care. 1989;12:364-368.
52. Jacques CHM, Jones RL. Problems encountered by primary care physicians in the care of diabetic patients. Arch Fam Med. 1993;2:739-741.
53. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977-986.
54. Konen JC, Summerson JS, Dignan MB. Family function, stress and locus of control: relationships to glycemia in adults with diabetes mellitus. Arch Fam Med. 1993;2:393-402.